Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines

Julie Scott, Robert T. Dorr, Betty Samulitis, Terry H. Landowski

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences